Daan Gene Co., Ltd. (SHE:002030)

China flag China · Delayed Price · Currency is CNY
6.35
+0.01 (0.16%)
Jul 18, 2025, 2:45 PM CST
28.80%
Market Cap8.90B
Revenue (ttm)823.85M
Net Income (ttm)-508.95M
Shares Out1.40B
EPS (ttm)-0.37
PE Ration/a
Forward PEn/a
Dividend0.02 (0.24%)
Ex-Dividend DateJun 14, 2024
Volume12,322,080
Average Volume18,458,423
Open6.36
Previous Close6.34
Day's Range6.28 - 6.38
52-Week Range4.71 - 7.32
Beta0.66
RSI58.68
Earnings DateAug 30, 2025

About Daan Gene

Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through Biological Products and Related Business and Financial Business segments. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coronavirus disease (COVID-19), pharmacogenomics, viral transport medium, human papillomavirus, human immunodeficiency virus, respiratory infections, public hea... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1988
Employees 1,730
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.